Despite the initial negative impact of the COVID-19 pandemic, the Asia Pacific aesthetic injectable market will grow rapidly through 2032. Players in this market will help to support growth through new and differentiated products; the emergence of domestic players with low-cost offerings will also expand the availability of aesthetic injectables and make them more affordable for patients. Demand for aesthetic injectables will also be spurred by the rising awareness and acceptability of these procedures, as well as a growing patient pool, including nontraditional patient groups such as men and younger individuals.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aesthetic injectables (including BTX and dermal fillers) in the Asia Pacific region from 2019 through 2032.
The aesthetic injectable market and competitive dynamics vary across the Asia Pacific countries covered.
How does growth vary in the different countries and market segments covered?
In which markets have domestic competitors achieved the most success, and why?
How are companies catering to country-specific trends to remain competitive?
There is a strong presence of both domestic competitors and MNCs in the Asia Pacific market for aesthetic injectables.
What factors have supported domestic competitors’ positions in the Asia Pacific aesthetic injectable market?
What strategies are MNCs implementing to remain competitive amidst strong local competition?
Innovations and improvements made to treatments and products entering the Asia Pacific market will support sales growth.
Which products have gained approval in the Asia Pacific region, and which ones are expected to emerge going forward?
How do these improved and novel products and treatments compare to existing ones in the market?
What are the factors that make a product successful in the aesthetic injectable market in the Asia Pacific market?
- Aesthetic Injectables - Market Insights - Asia Pacific
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Aesthetic Injectable Market, by Product Type, Asia Pacific (USD), 2019u20132032
- Aesthetic Injectable Market Landscape, Asia Pacific (USD), 2022 and 2032
- Competitive Highlights
- Aesthetic Injectable Revenue Market Share Rankings, by Product Type, Asia Pacific, 2022
- Competitive Insights
- Companies Mentioned
- Market Developments
- Recent Events in the Aesthetic Injectable Market, Asia Pacific
- Key Clinical Trials in the Aesthetic Injectable Market, Asia Pacific
- Emerging Products for the Aesthetic Injectable Market, Asia Pacific
- Geographies Covered
- Geographies Covered, Asia Pacific
- Average Currency Exchange Rates
- Procedures and Products Covered
- Aesthetic Injectables Procedures and Products Covered, Asia Pacific
- Key Report Updates
- Aesthetic Injectable Market
- Market Highlights
- Key Content Updates
- Asia Pacific Aesthetic Injectable Market Drivers
- Asia Pacific Aesthetic Injectable Market Limiters
- Aesthetic Injectable Market, by Product Type, Asia Pacific (USD), 2019u20132032
- Aesthetic Injectable Market, by Country, Asia Pacific (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Aesthetic Injectable Procedures, by Product Type, Asia Pacific, 2019u20132032
- Aesthetic Injectable Procedures, by Country, Asia Pacific, 2019u20132032
- Aesthetic Injectable Market, by Product Type, Asia Pacific (USD), 2019u20132032
- Aesthetic Injectable Market Growth, by Product Type, Asia Pacific, 2020u20132032
- Aesthetic Injectable Market, by Country, Asia Pacific (USD), 2019u20132032
- Aesthetic Injectable Market Growth, by Country, Asia Pacific, 2020u20132032
- Market Shares
- Aesthetic Injectable Revenue Market Shares, Asia Pacific, 2022
- Aesthetic Injectable Revenue Market Shares, by Product Type, Asia Pacific, 2022
- Competitive Insights
- Allergan (an AbbVie company) Competitive Insights
- Galderma Competitive Insights
- Competitive Insights for Other Key Competitors
- Market Developments
- Recent Events in the Aesthetic Injectable Market, Asia Pacific
- Key Clinical Trials in the Aesthetic Injectable Market, Asia Pacific
- Emerging Products for the Aesthetic Injectable Market, Asia Pacific
- Botulinum Toxin Market
- Market Highlights
- Key Content Updates
- Asia Pacific Botulinum Toxin Market Drivers
- Asia Pacific Botulinum Toxin Market Limiters
- BTX Market, by Country, Asia Pacific (USD), 2019u20132032
- Market Definitions
- Volume of BTX Product per Procedure, by Product Type
- Market Forecast Data
- BTX Procedures, by Country, Asia Pacific, 2019u20132032
- BTX Market, by Country, Asia Pacific (USD), 2019u20132032
- BTX Market Growth, by Country, Asia Pacific, 2020u20132032
- Market Shares
- BTX Revenue Market Shares, Asia Pacific, 2022
- BTX Revenue Market Shares, Asia Pacific, 2022
- Competitive Insights
- Dermal Filler Market
- Market Highlights
- Key Content Updates
- Asia Pacific Dermal Filler Market Drivers
- Asia Pacific Dermal Filler Market Limiters
- Dermal Filler Market, by Material, Asia Pacific (USD), 2019u20132032
- Dermal Filler Market, by Country, Asia Pacific (USD), 2019u20132032
- Market Definitions
- Volume of Dermal Filler Product per Procedure, by Product
- Market Forecast Data
- Dermal Filler Procedures, by Material, Asia Pacific, 2019u20132032
- Dermal Filler Procedures, by Country, Asia Pacific, 2019u20132032
- Dermal Filler Market, by Material, Asia Pacific (USD), 2019u20132032
- Dermal Filler Market Growth, by Material, Asia Pacific (USD), 2020u20132032
- Dermal Filler Market, by Country, Asia Pacific (USD), 2019u20132032
- Dermal Filler Market Growth, by Country, Asia Pacific (USD), 2020u20132032
- HA Dermal Filler Procedures, by Country, Asia Pacific, 2019u20132032
- HA Dermal Filler Market, by Country, Asia Pacific (USD), 2019u20132032
- HA Dermal Filler Market Growth, by Country, Asia Pacific, 2020u20132032
- Non-HA Dermal Filler Procedures, by Country, Asia Pacific, 2019u20132032
- Non-HA Dermal Filler Market, by Country, Asia Pacific (USD), 2019u20132032
- Non-HA Dermal Filler Market Growth, by Country, Asia Pacific, 2020u20132032
- Market Shares
- Dermal Filler Revenue Market Shares, Asia Pacific, 2022
- Dermal Filler Revenue Market Shares, Asia Pacific, 2022
- Competitive Insights
- Appendix
- Abbreviations
- Bibliography
Vaidruti Joshi, M.Pharm
Vaidruti Joshi is a research associate on the Orthopedics, Dental and Aesthetics Medtech Insights team at Clarivate, specializing in the field of dental implants. Vaidruti holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmacy specializing in Pharmaceutical Analysis from Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Karnataka.
Raghav Tangri, MRes
Raghav Tangri is a lead analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Clarivate, specializing in aesthetics device markets. Raghav has been featured in the Aesthetics Journal and has participated in several white papers on policy advocacy and analysis. Raghav also has expertise in the endoscopy device space, including the markets for gastrointestinal devices, open and laparoscopic devices, and hernia repair devices. Raghav holds a Bachelor’s degree in Biotechnology from Delhi Technological University and a Master’s degree in Life Sciences from Imperial College London.
Follow Raghav on Twitter:@rtangri_DRG